Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)

The National Institute of Biomedical Imaging and Bioengineering, with other institutes, intends to publish a Notice of Funding Opportunity to solicit applications for the Trailblazer Award. This award is for NIH-defined New and Early Stage Investigators to pursue research programs that integrate engineering and the physical sciences with the life and/or biomedical sciences. The project may be exploratory, developmental, proof of concept, or high-risk high-impact, and may be technology design-directed, discovery-driven, or hypothesis-driven. • The award will utilize the R21 activity code. • Collaborative investigations combining expertise in trans-disciplinary research approaches will be encouraged. • Investigators with expertise in engineering and quantitative sciences are encouraged to apply. • The estimated application response date is Feb 16, 2026, and the estimated award date is Oct 01, 2026.